review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Morgan Langille | Q53584922 |
Leah E Cahill | Q55714956 | ||
Johan Van Limbergen | Q91657927 | ||
P2093 | author name string | Amber MacLellan | |
Jessica Moore-Connors | |||
Shannan Grant | |||
P2860 | cites work | An anti-inflammatory diet as treatment for inflammatory bowel disease: a case series report | Q21245915 |
Enteral nutritional therapy for induction of remission in Crohn's disease | Q24243037 | ||
Linking long-term dietary patterns with gut microbial enterotypes | Q24609914 | ||
Nutrition in Pediatric Inflammatory Bowel Disease: From Etiology to Treatment. A Systematic Review | Q26748785 | ||
Functional analysis of colonic bacterial metabolism: relevant to health? | Q26851969 | ||
Induction of intestinal Th17 cells by segmented filamentous bacteria | Q28131638 | ||
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment | Q28710518 | ||
Diet rapidly and reproducibly alters the human gut microbiome | Q29547454 | ||
The gut microbiota shapes intestinal immune responses during health and disease | Q29547727 | ||
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients | Q29614261 | ||
Microbial influences in inflammatory bowel diseases | Q29614264 | ||
Functional interactions between the gut microbiota and host metabolism | Q29616815 | ||
A high-fiber diet may improve bowel function and health-related quality of life in patients with Crohn disease | Q30405495 | ||
Clinical and Fecal Microbial Changes With Diet Therapy in Active Inflammatory Bowel Disease | Q30490594 | ||
Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases | Q33691828 | ||
The treatment-naive microbiome in new-onset Crohn's disease | Q33762817 | ||
Beyond the Venn diagram: the hunt for a core microbiome | Q34049635 | ||
IBD-what role do Proteobacteria play? | Q34255700 | ||
Enteral nutrition support to treat malnutrition in inflammatory bowel disease. | Q34468970 | ||
Dietary and enteral interventions for Crohn's disease. | Q34547077 | ||
16S rRNA sequences reveal numerous uncultured microorganisms in a natural community | Q34570149 | ||
A detailed analysis of 16S ribosomal RNA gene segments for the diagnosis of pathogenic bacteria | Q34613216 | ||
Effect of exclusive enteral nutrition on the microbiota of children with newly diagnosed Crohn's disease | Q35565398 | ||
Inflammatory bowel disease pathogenesis: where are we? | Q35591299 | ||
Remission induced by an elemental diet in small bowel Crohn's disease | Q35603617 | ||
High throughput sequencing reveals distinct microbial populations within the mucosal and luminal niches in healthy individuals | Q35615264 | ||
Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease. | Q35653282 | ||
Treatment of active Crohn's disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial | Q35760202 | ||
The relationship between faecal-associated and mucosal-associated microbiota in irritable bowel syndrome patients and healthy subjects | Q35777558 | ||
Metabolome of human gut microbiome is predictive of host dysbiosis | Q35778932 | ||
Inflammation, Antibiotics, and Diet as Environmental Stressors of the Gut Microbiome in Pediatric Crohn's Disease | Q35807983 | ||
Extensive Modulation of the Fecal Metagenome in Children With Crohn's Disease During Exclusive Enteral Nutrition | Q35829641 | ||
Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease | Q35899065 | ||
Changes in fecal microbiota and metabolomics in a child with juvenile idiopathic arthritis (JIA) responding to two treatment periods with exclusive enteral nutrition (EEN). | Q35972166 | ||
Population-level analysis of gut microbiome variation | Q36002382 | ||
Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity | Q36002388 | ||
Anti-inflammatory effect of exclusive enteral nutrition in patients with juvenile idiopathic arthritis | Q36068915 | ||
Early Changes in Microbial Community Structure Are Associated with Sustained Remission After Nutritional Treatment of Pediatric Crohn's Disease. | Q36180180 | ||
Altered intestinal microbiota-host mitochondria crosstalk in new onset Crohn's disease | Q36201694 | ||
Dietary treatment of Crohn's disease: perceptions of families with children treated by exclusive enteral nutrition, a questionnaire survey. | Q36254326 | ||
Dysbiosis and the immune system | Q36297601 | ||
Enteral feeding in inflammatory bowel disease | Q36445187 | ||
Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ | Q36886503 | ||
Systematic review: nutritional therapy in paediatric Crohn's disease | Q37018094 | ||
Nutritional therapy for the treatment of pediatric Crohn's disease | Q37769254 | ||
Fermentation in the human large intestine: its physiologic consequences and the potential contribution of prebiotics | Q37944977 | ||
Techniques used to characterize the gut microbiota: a guide for the clinician. | Q37997281 | ||
Effects of enteral nutrition on Crohn's disease: clues to the impact of diet on disease pathogenesis | Q38080687 | ||
Gut microbiota imbalance and chaperoning system malfunction are central to ulcerative colitis pathogenesis and can be counteracted with specifically designed probiotics: a working hypothesis | Q38122352 | ||
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease. | Q38218604 | ||
Treatment of IBD: where we are and where we are going | Q38285619 | ||
Review article: insights into colonic protein fermentation, its modulation and potential health implications | Q38623020 | ||
Specific carbohydrate diet for pediatric inflammatory bowel disease in clinical practice within an academic IBD center | Q38665757 | ||
Novel Strategies for Applied Metagenomics. | Q38723919 | ||
An overview of the bacterial contribution to Crohn disease pathogenesis. | Q38921955 | ||
High Dietary Intake of Specific Fatty Acids Increases Risk of Flares in Patients With Ulcerative Colitis in Remission During Treatment With Aminosalicylates | Q39007572 | ||
Inflammatory disease caused by intestinal pathobionts | Q39131979 | ||
Fermentable Carbohydrate Restriction (Low FODMAP Diet) in Clinical Practice Improves Functional Gastrointestinal Symptoms in Patients with Inflammatory Bowel Disease. | Q39176115 | ||
The Gut Microbiome of Pediatric Crohn's Disease Patients Differs from Healthy Controls in Genes That Can Influence the Balance Between a Healthy and Dysregulated Immune Response | Q39270927 | ||
The Role of Carrageenan and Carboxymethylcellulose in the Development of Intestinal Inflammation | Q39308885 | ||
Exclusive enteral nutrition induces early clinical, mucosal and transmural remission in paediatric Crohn's disease. | Q39426548 | ||
A survey of people with inflammatory bowel disease to investigate their views of food and nutritional issues. | Q39819214 | ||
Is the abundance of Faecalibacterium prausnitzii relevant to Crohn's disease? | Q42400202 | ||
Exclusive enteral nutrition in children with Crohn's disease | Q42533686 | ||
An altered gut microbiome profile in a child affected by Crohn's disease normalized after nutritional therapy | Q43172056 | ||
Toward enteral nutrition for the treatment of pediatric Crohn disease in Canada: a workshop to identify barriers and enablers | Q43213523 | ||
Consensus and controversy in the management of pediatric Crohn disease: an international survey | Q44376941 | ||
Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease. | Q45724455 | ||
Decline in presumptively protective gut bacterial species and metabolites are paradoxically associated with disease improvement in pediatric Crohn's disease during enteral nutrition. | Q46916293 | ||
Probiotics, prebiotics and symbiotics in inflammatory bowel diseases: state-of-the-art and new insights | Q46952439 | ||
Enteral feeding reduces metabolic activity of the intestinal microbiome in Crohn's disease: an observational study. | Q51526038 | ||
Role of Diet in Inflammatory Bowel Disease. | Q51674429 | ||
Early Mucosal Healing with Exclusive Enteral Nutrition is Associated with Improved Outcomes in Newly Diagnosed Children with Luminal Crohn's disease. | Q53146844 | ||
Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis. | Q54288748 | ||
Changes of faecal microbiota in patients with Crohn's disease treated with an elemental diet and total parenteral nutrition. | Q54308527 | ||
Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. | Q54372805 | ||
Low counts of Faecalibacterium prausnitzii in colitis microbiota. | Q54493669 | ||
Polymeric Diet Alone Versus Corticosteroids in the Treatment of Active Pediatric Crohn’s Disease: A Randomized Controlled Open-Label Trial | Q57804359 | ||
Effects of enteral polymeric diet on gut microbiota in children with Crohn's disease | Q58064978 | ||
Comparison of Outcomes Parameters for Induction of Remission in New Onset Pediatric Crohnʼs Disease | Q62051498 | ||
Dietary patterns and risk for Crohn's disease in children | Q80230030 | ||
Enteral nutrition and microflora in pediatric Crohn's disease | Q81890970 | ||
Sustained modulation of intestinal bacteria by exclusive enteral nutrition used to treat children with Crohn's disease | Q83189238 | ||
Food-specific IgG4-guided exclusion diets improve symptoms in Crohn's disease: a pilot study | Q84564403 | ||
Exclusive enteral nutrition in active pediatric Crohn disease: Effects on intestinal microbiota and immune regulation | Q87480793 | ||
Partial enteral nutrition with a Crohn's disease exclusion diet is effective for induction of remission in children and young adults with Crohn's disease | Q88194870 | ||
P275 | copyright license | Creative Commons Attribution | Q6905323 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | microbiome | Q1330402 |
environment | Q2249676 | ||
Crohn's disease | Q1472 | ||
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P577 | publication date | 2017-05-01 | |
P1433 | published in | Nutrients | Q7070485 |
P1476 | title | The Impact of Exclusive Enteral Nutrition (EEN) on the Gut Microbiome in Crohn's Disease: A Review | |
P478 | volume | 9 |
Q64890601 | A Review of Dietary Therapy for IBD and a Vision for the Future. |
Q90581746 | Elemental diet induces alterations of the gut microbial community in mice |
Q90192988 | Enteral Nutrition in Adult Crohn's Disease: Toward a Paradigm Shift |
Q61804908 | Fecal microbiota profiles in treatment-naïve pediatric inflammatory bowel disease - associations with disease phenotype, treatment, and outcome |
Q93041520 | Importance of nutritional therapy in the management of intestinal diseases: beyond energy and nutrient supply |
Q46375902 | Living on Liquids: Surviving and Thriving on Exclusive Enteral Nutrition |
Q57821771 | Perioperative Care of Patients with Inflammatory Bowel Disease: Focus on Nutritional Support |
Q64930812 | Preoperative Enteral Nutrition and Surgical Outcomes in Adults with Crohn's Disease: A Systematic Review. |
Q39354624 | Preoperative Nutritional Conditioning of Crohn's Patients-Systematic Review of Current Evidence and Practice. |
Q92180014 | The microbiome, cancer, and cancer therapy |
Q91657932 | The relationship between fecal bile acids and microbiome community structure in pediatric Crohn's disease |
Q58787245 | Variability of core microbiota in newly diagnosed treatment-naïve paediatric inflammatory bowel disease patients |
Search more.